Abbott, Novo Nordisk partner to provide integrated digital solution to people with diabetes using insulin
Abbott, a global healthcare leader and Novo Nordisk announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled... Read More
Abbott to acquire medical device company, Cephea Valve Technologies
Abbott, a global healthcare company, announced that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical... Read More
Abbott receives US FDA approval for its fully dissolving heart stent, Absorb bioresorbable stent
Abbott announced that the US Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device... Read More
Strategic Deal: Abbott to Acquire Alere
Abbott and Alere Inc. announced today a definitive agreement for Abbott to acquire Alere, significantly advancing Abbott’s global diagnostics presence and leadership.... Read More
Novozyme Ranked 1 in among top 20 global biotech employers for 2015
Posted on03 Nov 2015
TagsAbbott, AbbVie, Alexion Pharmaceuticals, Bayer, Biocon, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, gilead, Merck KGaA, Moderna Therapeutics, Monsanto Company, Novozymes, Regeneron Pharmaceuticals Novo Nordisk, Roche—excluding Genentech, Top 10 Biotech company globally, vertex pharmaceuticals
Comments0
Novozymes has earned 1st rank globally on top biotechnology employers in the world as ranked by American Association for the Advancement of Science (AAAS).... Read More